» Articles » PMID: 10615904

Pathogenesis of Diverse Clinical and Pathological Phenotypes in Hypertrophic Cardiomyopathy

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2000 Jan 1
PMID 10615904
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Myocardial contractility is generally believed to be increased in hypertrophic cardiomyopathy. I propose the opposite--that cardiac myocyte contractility is decreased in this disorder. Accordingly, the contractile deficit provides the primary stimulus for increased expression of trophic factors in the heart, which leads to hypertrophy, interstitial fibrosis, and other phenotypes. Variation among individuals in expression of trophic factors would account for the variability of phenotypes. Gene transfer studies in cardiac myocytes showing impaired contractility and increased expression of trophic factors in the myocardium of patients with hypertrophic cardiomyopathy support this hypothesis. Testing of the hypothesis would require measurement of contractility of cardiac myocytes isolated from patients with hypertrophic cardiomyopathy, identification of the main trophic factors in the hearts of these patients, and investigation of whether their inhibition can prevent or lead to regression of the cardiac phenotypes.

Citing Articles

Hypertrophic Cardiomyopathy with Special Focus on Mavacamten and Its Future in Cardiology.

Mlynarska E, Radzioch E, Dabek B, Leszto K, Witkowska A, Czarnik W Biomedicines. 2025; 12(12.

PMID: 39767581 PMC: 11727519. DOI: 10.3390/biomedicines12122675.


Obstructive hypertrophic cardiomyopathy: from genetic insights to a multimodal therapeutic approach with mavacamten, aficamten, and beyond.

Sarwer K, Lashari S, Rafaqat N, Maher , Raheem A, Rehman M Egypt Heart J. 2024; 76(1):156.

PMID: 39645546 PMC: 11625047. DOI: 10.1186/s43044-024-00587-y.


Causes and consequences of DNA double-stranded breaks in cardiovascular disease.

Marian A Mol Cell Biochem. 2024; .

PMID: 39404936 DOI: 10.1007/s11010-024-05131-9.


Myocardial contractility characteristics of hypertrophic cardiomyopathy patients with and without sarcomere mutation.

Zhang J, Li J, Wang B, Wang J, Hu R, Shan B Heart Vessels. 2024; 39(11):939-948.

PMID: 38806839 DOI: 10.1007/s00380-024-02414-5.


Morphological and Genetic Aspects for Post-Mortem Diagnosis of Hypertrophic Cardiomyopathy: A Systematic Review.

Cianci V, Forzese E, Sapienza D, Cardia L, Cianci A, Germana A Int J Mol Sci. 2024; 25(2).

PMID: 38279275 PMC: 10816624. DOI: 10.3390/ijms25021275.